(Q48237916)

English

Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

David M. Holtzman

7

object named as

David M Holtzman

1 reference

Europe PubMed Central

9 February 2018

6

object named as

Anne M Fagan

1 reference

Europe PubMed Central

9 February 2018

8

object named as

John C Morris

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

1

object named as

John S K Kauwe

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

2

object named as

Sarah Jacquart

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

Sumi Chakraverty

3

object named as

Sumi Chakraverty

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

author name string

Jun Wang

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

Kevin Mayo

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

publication date

1 May 2007

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

Annals of Neurology

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

61

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

446-453

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1002%2FANA.21099

21 January 2018

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

1 reference

https://api.crossref.org/works/10.1002%2FANA.21099

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls.

1 reference

https://api.crossref.org/works/10.1002%2FANA.21099

21 January 2018

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1002%2FANA.21099

21 January 2018

Identifiers

10.1002/ANA.21099

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/17366635

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48237916&oldid=2130407634"